Sessions
- AML: Clinical and Epidemiological studies
- Treatments and Outcomes in AML in Specific Age Groups, and in Blastic Plasmacytoid Dendritic Cell Neoplasms: Saturday, December 7, 2024: 4:00 PM-5:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Frailty, Age, and Care Provisions-Impact on AML Outcomes: Sunday, December 8, 2024: 9:30 AM-11:00 AM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Genetic Markers and Outcomes in AML: Monday, December 9, 2024: 2:45 PM-4:15 PM Grand Hall C (Manchester Grand Hyatt San Diego)
- AML: Investigational Drug and Cellular Therapies
- AML: Commercially Available Therapies:
- Impact of Molecularly-Targeted Agents in AML: Saturday, December 7, 2024: 2:00 PM-3:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- How Do We Start? Upfront Regimens with Commercially Available Therapies: Saturday, December 7, 2024: 9:30 AM-11:00 AM Hall B (San Diego Convention Center)
- Optimizing Regimens in Children/Young Adults and Around the World: Monday, December 9, 2024: 4:30 PM-6:00 PM Grand Hall B (Manchester Grand Hyatt San Diego)
- AML: Biomarkers and Molecular Markers in Diagnosis and Prognosis:
- Multi-omic Applications for Disease Evolution and Response to Therapy: Saturday, December 7, 2024: 9:30 AM-11:00 AM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Functional Genomics in Prognosis and Novel Therapies: Saturday, December 7, 2024: 4:00 PM-5:30 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
- Deciphering the Mechanisms Underlying Prognosis: Sunday, December 8, 2024: 4:30 PM-6:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
- Refining Diagnostic Risk Assessment: Monday, December 9, 2024: 2:45 PM-4:15 PM Grand Hall B (Manchester Grand Hyatt San Diego)
- AML: Disease Burden and Minimal Residual Disease in Prognosis and Treatment
- AML Links to Poster Sessions